Biocan Novel DHPPi/L4R, Lyophilisate and solvent for suspension for injection
Biocan Novel DHPPi/L4R, Lyophilisate and solvent for suspension for injection
Authorised
- Canine distemper virus, strain CDV Bio 11/A, Live
- Canine adenovirus 2, strain CAV-2-Bio 13, Live
- Canine parvovirus 2b, strain CPV-2b Bio 12/B, Live
- Canine parainfluenza virus 2, strain CPiV-2-Bio 15, Live
- Leptospira interrogans, serogroup Icterohaemorrhagiae, serovar Icterohaemorrhagiae, strain MSLB 1089, Inactivated
- Leptospira interrogans, serogroup Canicola, serovar Canicola, strain MSLB 1090, Inactivated
- Rabies virus, strain SAD Vnukovo-32, Inactivated
- Leptospira interrogans, serogroup Australis, serovar Bratislava, Inactivated
- Leptospira kirschneri, Serogroup Grippotyphosa, Inactivated
Product identification
Medicine name:
Biocan Novel DHPPi/L4R, Lyophilisate and solvent for suspension for injection
Biocan Novel DHPPi/L4R - лиофилизат и суспензия за инжекционна суспензия за кучета
Active substance:
- Canine distemper virus, strain CDV Bio 11/A, Live
- Canine adenovirus 2, strain CAV-2-Bio 13, Live
- Canine parvovirus 2b, strain CPV-2b Bio 12/B, Live
- Canine parainfluenza virus 2, strain CPiV-2-Bio 15, Live
- Leptospira interrogans, serogroup Icterohaemorrhagiae, serovar Icterohaemorrhagiae, strain MSLB 1089, Inactivated
- Leptospira interrogans, serogroup Canicola, serovar Canicola, strain MSLB 1090, Inactivated
- Rabies virus, strain SAD Vnukovo-32, Inactivated
- Leptospira interrogans, serogroup Australis, serovar Bratislava, Inactivated
- Leptospira kirschneri, Serogroup Grippotyphosa, Inactivated
Target species:
-
Dog
Route of administration:
-
Subcutaneous use
Product details
Active substance and strength:
-
Canine distemper virus, strain CDV Bio 11/A, Live5.10log10 tissue culture infective dose 501.00Dose
-
Canine adenovirus 2, strain CAV-2-Bio 13, Live5.30log10 tissue culture infective dose 501.00Dose
-
Canine parvovirus 2b, strain CPV-2b Bio 12/B, Live6.60log10 tissue culture infective dose 501.00Dose
-
Canine parainfluenza virus 2, strain CPiV-2-Bio 15, Live5.10log10 tissue culture infective dose 501.00Dose
-
Leptospira interrogans, serogroup Icterohaemorrhagiae, serovar Icterohaemorrhagiae, strain MSLB 1089, Inactivated51.00Antibody microagglutination-lytic reaction1.00Dose
-
Leptospira interrogans, serogroup Canicola, serovar Canicola, strain MSLB 1090, Inactivated51.00Antibody microagglutination-lytic reaction1.00Dose
-
Rabies virus, strain SAD Vnukovo-32, Inactivated2.00international unit(s)1.00Dose
-
Leptospira interrogans, serogroup Australis, serovar Bratislava, Inactivated51.00Antibody microagglutination-lytic reaction1.00Dose
-
Leptospira kirschneri, Serogroup Grippotyphosa, Inactivated40.00Antibody microagglutination-lytic reaction1.00Dose
Pharmaceutical form:
-
Lyophilisate and solvent for suspension for injection
Withdrawal period by route of administration:
-
Subcutaneous use
- Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI07AJ06
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Bulgaria
Package description:
- Glass Vial 50 x 1.0 Dose
- Glass Vial 25 x 1.0 Dose
- Glass Vial 10 x 1.0 Dose
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Bioveta a.s.
Marketing authorisation date:
Manufacturing sites for batch release:
- Bioveta a.s.
Responsible authority:
- Bulgarian Agency For Food Safety
Authorisation number:
- 0022-2368
Date of authorisation status change:
Reference member state:
-
Czechia
Procedure number:
- CZ/V/0119/001
Concerned member states:
-
Bulgaria
-
Croatia
-
Cyprus
-
Estonia
-
Hungary
-
Latvia
-
Lithuania
-
Poland
-
Romania
-
Slovakia
-
Slovenia
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Combined File of all Documents
This document does not exist in this language (English). You can find it in another language below.
Bulgarian (PDF)
Published on: 21/02/2022
How useful was this page?: